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ABSTRACT Koch’s postulates are criteria establishing a causal relationship between a microbe and a disease that lead to the as-
sumption that diseases are caused by a single strain or its evolved forms. Cryptococcus neoformans is a life-threatening human
fungalpathogenresponsibleforanestimated1millioncasesofcryptococcosis/year,predominantlymeningoencephalitis.To
assessthemoleculardiversityofclinicalisolatesandgainknowledgeof C.neoformansbiologyinthehost,weanalyzedclinical
culturescollectedduringtheprospectiveCryptoA/Dstudy.Usingmolecularanalysisofunpuriﬁedisolates,wedemonstrated
thatmixedinfectionsinhumansaremorecommonthanpreviouslythought,occurringinalmost20%ofpatientsdiagnosed
withcryptococcosis.Thesemixedinfectionsarecomposedofdifferentmatingtypes,serotypes,and/orgenotypes.Wealsoiden-
tiﬁedgeneticallyrelatedhaploidanddiploidstrainsinthesamepatients.ExperimentalinfectionsandquantitativePCRshow
thattheseploidychangescanresultfromendoreplication(duplicationofDNAcontent)andthatshuttlingbetweenhaploidand
diploid states can occur, suggesting in vivo evolution. Thus, the concept of one strain/one infection does not hold true for C. neo-
formansandmayapplytootherenvironmentallyacquiredfungalpathogens.Furthermore,thepossibilityofmixedand/or
evolvinginfectionsshouldbetakenintoaccountwhendevelopingtherapeuticstrategiesagainstthesepathogens.
IMPORTANCE Cryptococcus neoformans is a life-threatening human fungal pathogen that is present in the environment and is
responsibleforanestimated1millioncasesofcryptococcosis/year,predominantlymeningoencephalitisinHIV-infectedpa-
tients.Toassessthemoleculardiversityofclinicalisolatesandgainknowledgeof C.neoformansbiologyinthehost,weanalyzed
clinicalculturescollectedduringaprospectivestudyoncryptococcosis.Usingmolecularanalysisofunpuriﬁedisolates,weun-
coveredanunexpectedlyhighfrequency(almost20%)ofmixedinfections.Wefurtherdemonstratedthatthesemixedinfections
couldresultfrominfestationbymultiplestrainsacquiredfromtheenvironment.Wealsomadetheserendipitousdiscoveryof in
vivoevolutionleadingtoendoreplicationoftheyeastswithinthehost.Thus,theconceptofonestraincausingoneinfectiondoes
notholdtrueforC.neoformansandpotentiallyforotherenvironmentallyacquiredfungalpathogens.Thepossibilityofmixed
and/orevolvinginfectionsshouldbetakenintoaccountwhendevelopingtherapeuticstrategiesagainstthesepathogens.
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C
ryptococcus neoformans is a haploid encapsulated yeast re-
sponsible for cryptococcosis, an opportunistic infection that
occurs in patients with cellular immune defects, especially those
with AIDS. Cryptococcosis affects up to 30% of HIV-infected pa-
tientsinsub-SaharanAfricaandSoutheastAsia(1).Overall,cryp-
tococcal meningoencephalitis is diagnosed in almost 1 million
individuals per year, accounting for more than 600,000 deaths
annually (2). Cryptococcosis is still fatal in almost 20% of cases
despite adequate treatment, justifying the development of new
therapeuticstrategies.C.neoformansisubiquitousintheenviron-
ment, particularly in bird droppings and decaying vegetation. It
exists in two varieties, C. neoformans var. grubii (serotype A), which
causes the majority of infections worldwide, and C. neoformans var.
neoformans (serotype D), which is commonly found in Europe.
Cryptococcosis is usually considered to represent the reactiva-
tion of a dormant infection (1). A single isolate of C. neoformans
has been thought to be responsible for the disease. Yet the isola-
tionofstrainswithdifferentgenotypes,serotypes,ormatingtypes
at the same geographic site (3, 4) makes infestation by multiple
strains likely. Only anecdotal reports of mixed infections have
been published to date. In mixed infections involving different
species or serotypes of Cryptococcus, multiple single-colony iso-
lateswereanalyzedduetovastlydifferentcolonymorphologies(5,
6). In other cases, different genotypes of C. neoformans var. grubii
havebeenidentiﬁedintemporallyseparatedsingle-colonyisolates
during the same episode or during a relapse of infection (7–11).
Microevolutionduringinfectionhasbeensuggestedandshownto
occur during long-term storage and repeated passage in the labo-
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studies to be carried out with unpuriﬁed isolates to determine the
true incidence of mixed infections (6, 15) because routine clinical
practice (storage of a single colony per isolate, one isolate studied
per patient, and no routine detection of ploidy or mating type)
precludes the discovery of mixed infections.
Identiﬁcation of sexual cycles in the pathogenic fungi greatly
expandedourunderstandingoftheirbiology(16–18).Thesexual
cycle of C. neoformans involves mating types a and  (MATa and
MAT),butsexualreproductionseemslimitedbyapparentlyrare
encounters with sexual partners (17, 19). However, recombina-
tion is observed, potentially due to monokaryotic fruiting follow-
ing same-sex cell fusion or self-diploidization (also called en-
doreplication) with the production of recombinant haploid or
diploid progenies (20–23). AD hybrid strains of C. neoformans
var. neoformans and grubii have also been identiﬁed. These hy-
brids can harbor both mating types or result from same-sex mat-
ing (24, 25). Hybrids have been observed in nature and in clinical
samples and have been generated in the laboratory (26, 27). The
ability to undergo mating or endoreplication is assumed to allow
responsetoenvironmentalandhostchallengesandcontributesto
geneticdiversity(28).Todate,experimentalinfectionswithlabo-
ratory reference strains have not revealed stable ploidy changes
(29).
The scarcity of mixed-infection reports could be explained ei-
therbytheirtruerarityorbythefactthatmostclinicalisolatesare
single colony puriﬁed prior to molecular analysis. Our objective
was to analyze isolates that were not colony puriﬁed to determine
the frequency of mixed infections and if AD hybrid formation,
mating, or monokaryotic fruiting could occur in vivo because of
the simultaneous presence of multiple strains. For these analyses,
weusedacollectionofclinicalisolatesthatweresentunpuriﬁedto
the French National Reference Center for Mycoses and Antifun-
gals(NRCMA)duringtheprospectiveCryptoA/Dstudy(30).Our
analysis represents the ﬁrst estimate of mixed infections during
cryptococcosis. Various combinations of strains with different
mating types, serotypes, ploidies, and genotypes were found dur-
ing the same episode of cryptococcosis, sometimes in the same
sample.Whilematingandhybridformationcouldnotbedemon-
strated in vivo, diploidization resulting from endoreplication was
documented and enhanced the diversity of infecting strains.
RESULTS
Mixed infections are frequent and diverse during cryptococco-
sis. We examined 100 isolates corresponding to 49 patients for
whomC.neoformansunpuriﬁedoriginalcultureshadbeenstored
during the CryptoA/D study (30). Single-colony isolates (4 to 33
single colonies/culture) were screened for all 100 cultures. Origi-
nalculturesandsingle-colonyisolateswereanalyzedforploidyby
ﬂow cytometry, and genotypes were determined by ampliﬁcation
of serotype- and mating-type-speciﬁc loci by PCR.
Mixed infections were demonstrated for 9/49 patients studied
(18.4%). A total of 31 original cultures (15 from cerebrospinal
ﬂuid [CSF] samples, 10 from blood cultures, 4 from urine sam-
ples, 1 from a skin lesion, and 1 from a bronchoalveolar lavage
[BAL] ﬂuid sample) and 286 single-colony isolates from these
ninepatientswerestudied.Amongthe31originalcultures,8were
found to be diploid and 23 were haploid (Table 1). Subsequent
analysis of single-colony isolates derived from the eight diploid
cultures showed that strains with different ploidies, serotypes, or
mating types could be found in the same culture for six patients
(Table1).Differentstrainswerealsofoundatdifferentanatomical
sites and at different time points during infection (up to 15 days)
for seven patients. Using multilocus sequence typing (MLST), in-
fection by two genetically distinct isolates of C. neoformans var.
grubii was found for one patient (no. 188) with differences in 4/8
loci (Table 1). Overall, mixed infections with different serotypes,
mating types, ploidies and/or genotypes in various combinations
were observed as follows: A  D (patient no. 188), A  Da
(no.71),AADa(no.10and198),AAA(no.161),A
DD(no.20and23),DaaDDa(no.119),andAD
ADDD(no.177).Patientswithmixedinfectionsdidnot
differ signiﬁcantly from those with single infections in terms of
underlying disease and clinical presentation. However, a trend
towardmoremycologicalfailuresafter2weeksofantifungaltreat-
ment but reduced mortality was observed in the mixed-infection
group (Table 2).
Multiple infestations are responsible for mixed infections
during cryptococcosis. The discovery of haploid and AD hybrid
diploid isolates in the same patient suggested that either these
ploidy changes occurred in the environment with subsequent in-
halation of multiple strains or they occurred within the human
host. MLST analysis was used to differentiate between these two
possibilities. Three patients (no. 177, 10, and 198) had infections
with haploid A and diploid AD or ADa hybrid strains.
MLSTanalysisofthesethreeserotypeApolymorphiclocirevealed
thatinallcasestheAallelesdifferedbetweenthehaploidandthe
hybrid strains (Table 1). These results ruled out genetic related-
ness between the A and AD isolates and showed that the haploid
AcouldnothavearisenfromunstableADdiploidsthatdropped
the D portion of their genome. These results, together with the
discovery of serotype A and D strains during the same episode of
cryptococcosis in ﬁve patients (no. 20, 23, 71, 177, and 188), pro-
vided evidence for coinfection with genetically distinct strains ac-
quired from the environment.
Diploidization can occur in vivo to generate mixed infec-
tions during cryptococcosis. In four patients infected with both
haploidanddiploidA(no.161),Da(no.71and119),orD(no.
177) strains, the infections could have resulted from either coin-
festation with genetically unrelated or related strains or in vivo
diploidization through same-sex cell fusion or endoreplication.
The A haploid and diploid strains had the same MLST proﬁle
(Table 1). Haploid and diploid serotype D strains from the same
patient shared the same MLST proﬁle, even though each patient
wasinfectedwithanevolutionarilydistinctstrain(Table1).Given
theobservedgenotypicdiversityofstrains(sixgenotypesrecorded
for nine patients infected with serotype A strains and ﬁve geno-
types for six patients infected with serotype D strains), the most
likely explanation for the genetic relatedness between the haploid
and diploid isolates is either cell fusion between genetically iden-
tical cells or endoreplication within the host or in nature.
To determine whether these ploidy changes could have oc-
curredinvivo,weinfectedmicewiththeAhaploidsingle-colony
isolate (AD 7-99, patient no. 161) in two independent experi-
ments. Two diploid  strains out of 330 single colonies studied
were recovered from two mouse brains at 9 and 15 days postin-
oculation (Fig. 1a). They were genetically identical to AD 7-99 by
MLST analysis. Interestingly, while the patient-derived haploid
and diploid single-colony isolates were equally virulent in mice, a
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P  0.001).
We then assessed whether diploid strains were stable in vivo.
Groupsofmicewereinoculatedwiththeclinicaldiploidstrain
TABLE 1 Molecular characteristics of C. neoformans isolates causing mixed infections in nine patients with cryptococcosis
Patient no.
and original
culture no.
Site of
isolation
Days since
1st positive
culture
Original culturea Single coloniesa
Ploidyb
Serotype/
mating
type
No.
studied Ploidyb
Serotype/
mating
type
MLST proﬁlec
CAP59/URA5/GPD1/SOD1/LAC1/IGS1/PLB1/TEF1
188
AD 1-26 CSF 0 n A 5nA  7/1/1/13/9/19/1/1
AD 1-35 Urine 0 n D 5nD  1/1/1/1/1/4/3/2
AD 1-36 Blood 0 n AD 24 n A 1/1/1/13/3/21/4/4
AD 1-12 Blood 4 n A 5nA  7/1/1/13/9/19/1/1
AD 1-28 Blood 5 n A 4nA  7/1/1/13/9/19/1/1
AD 1-29 CSF 6 n A 4nA  7/1/1/13/9/19/1/1
AD 1-30 BAL ﬂuid 9 n A 4nA  7/1/1/13/9/19/1/1
AD 1-13 CSF 11 n A 5nA  7/1/1/13/9/19/1/1
AD 1-14 CSF 13 n A 4nA  7/1/1/13/9/19/1/1
AD 1-15 Blood 16 n A 4nA  7/1/1/13/9/19/1/1
119
AD 1-60 CSF 0 n Da 6nD a 2/3/1/2/1/4/3/3
42 n aDDa 2/3/1/2/1/4/3/3
AD 1-61 Blood 1 2n Da 42 n aDDa 2/3/1/2/1/4/3/3
161
AD 1-77 Blood 0 n A 4nA  1/1/3/13/5/19/2/5
12 n AA 1/1/3/13/5/19/2/5
AD 1-76 CSF 1 n AD 26 n A 1/1/3/13/5/19/2/5
AD 1-78 CSF 15 n A 5nA  1/1/3/13/5/19/2/5
20
AD 3-28 CSF 0 n AD 9nA  7/1/1/13/9/19/1/1
AD 3-29 Urine 0 2n D 52 n DD 1/4/1/1/2/3/2/44
23
AD 4-5 CSF 0 n AD 17 n A 7/2/1/13/2/19/1/1
52 n DD 1/1/1/1/2/4/3/2
AD 4-6 CSF 15 2n D 52 n DD 1/1/1/1/2/4/3/2
177
AD 4-20 Skin 0 n D 11 n D 1/4/1/1/2/3/2/4
2nA  7/1/1/13/9/19/1/1
AD 4-22 Urine 4 2n D 42 n DD 1/4/1/1/2/3/2/4
12 n AD ///13///2/5
AD 4-23 CSF 5 2n D 52 n DD 1/4/1/1/2/3/2/4
71
AD 4-24 CSF 0 n Da 10 n Da 3/2/1/1/3/1/1/1
AD 4-25 Urine 0 n Da 5nD a 3/2/1/1/3/1/1/1
AD 4-26 Blood 0 n Da 4nD a 3/2/1/1/3/1/1/1
12 n aDDa 3/2/1/1/3/1/1/1
AD 4-27 CSF 14 n ADa 2nA  1/1/1/13/3/21/4/3
11 n Da 3/2/1/1/3/1/1/1
AD 4-64 CSF 0 n ADa 10 n A 7/1/1/13/9/19/1/1
12 n ADa ///13///3/20
198
AD 6-53 Blood 0 2n ADa 52 n ADa ///13///3/20
AD 4-58 CSF 0 2n ADa 52 n ADa ///13///3/20
AD 5-13 Blood 7 2n ADa 52 n ADa ///13///3/20
AD 5-14 Blood 7 n A 5nA  1/1/3/13/5/19/2/5
a Original culture, unpuriﬁed culture from clinical sample; single colony, puriﬁed single colony from corresponding clinical culture.
b Ploidy was determined by ﬂow cytometry; n, haploid; 2n, diploid.
c Genotypes were determined for serotype A and serotype D isolates by using eight loci selected by the MLST method. For AD hybrid isolates, allelic proﬁles were determined for
CAP10 and URE1 (27) and for SOD1, PLB1, and TEF1 loci with serotype A-speciﬁc primers speciﬁcally designed for this study. All of the AD hybrid and A strains studied had the
same nucleotide sequences for the CAP10 and URE1 loci. New alleles are in bold italics, serotype D alleles are underlined, and serotype A alleles are without underlining.
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405 colonies studied from brain and lung homogenates plated at
various times after inoculation, one haploid colony was discov-
ered. These data show that both positive and negative shifts in
ploidy occur in vivo.
In vivo diploidization can result from endoreplication. For
cell fusion to occur in vivo, different cell types need to interact.
Experimental coinfection with KN99a and KN99 inoculated
separatelyrevealedthatbothcelltypesarevisualizedinclosecon-
tactwithincapillaries(Fig.2),showingthatcellfusionisphysically
possible. Since ploidy changes could result from cell fusion or
endoreplication, a nourseothricin (NAT)-resistant isolate (AD 1-
25) was constructed from the wild-type AD 7-99 strain. Analysis
of DNA content by ﬂow cytometry following coinfection of six
mice with the NAT-resistant and wild-type strains resulted in
11.9% (30/251) diploid NAT-resistant single colonies. These dip-
loid isolates were found in both brains and lungs at days 7 and 15
postinoculation. Quantitative PCR analysis of 30 diploid and six
haploid NAT-resistant single-colony isolates was used to deter-
mine whether diploid isolates had the same (endoreplication) or
half (cell fusion) the amount of NAT DNA compared to a control
region of the genome present in both cell types (chitin synthase,
CHS1). Quantitative PCR analysis resulted in equivalent gene
copy numbers in both the diploid and haploid isolates (mean
crossing point ratio between ampliﬁcation of the CHS1 gene and
the NAT gene  1.03  0.02 for both haploid and diploid strains
[Table 3]), suggesting that the diploid strains resulted from en-
doreplication and not cell fusion.
DISCUSSION
The concept of one strain/one infection is assumed to be valid for
the majority of infectious diseases. Recent studies have used de-
termination of susceptibility to anti-infective drugs, sequence-
based approaches, and metagenomic analyses to assess microbial
diversity during infection or colonization (31, 32). There is evi-
dence that infections with a number of bacteria, viruses, and par-
asites may not be clonal. Coinfection with strains of Plasmodium
falciparum exhibiting different patterns of susceptibility to anti-
malarial drugs are correlated with treatment failure (33). Shigella
ﬂexneri strains with multiple plasmids suggest polyclonal infec-
tions(34).Sputumsamplesfrompatientswithactivetuberculosis
have been shown to contain multiple strains of Mycobacterium
tuberculosis (35). Different strains of hepatitis C virus or HIV,
TABLE 2 Characteristics of patients with and without mixed cryptococcal infections
Patient characteristic
Value for patients with:
P value Mixed infection (n  9) No mixed infection (n  40)
No. of males/totala (%) 9/9 (100) 34/40 (85) 0.577
Mean age (yr)  SD 44  12 44  14 0.912
No. HIV infected/total (%) 7/9 (78) 30/40 (75) 1.000
No. HIV positive with antiretroviral therapy /total (%) 2/7 (29) 12/29 (41) 0.681
No. born in Africa/total (%) 1/9 (11) 4/40 (10) 1.000
Presentation at baseline
No. with abnormal neurology/total (%) 4/9 (44) 15/40 (37.5) 0.720
No. with meningoencephalitis/total (%) 9/9 (100) 29/34 (83) 0.319
No. with fungemia/total (%) 5/9 (56) 17/38 (45) 0.715
No. with dissemination/total (%) 7/9 (78) 24/40 (60) 0.454
No. with high serum antigen titer (512)/total (%) 4/9 (44) 13/36 (37) 0.716
No. with abnormal brain imaging/total (%) 2/9 (22) 8/29 (26) 1.000
No. with mycological failure at day 15b/total (%) 5/8 (62.5) 10/32 (31.2) 0.126
No. who died within 90 days after diagnosis/total (%) 0/8 9/37 (24) 0.179
a Total number of patients evaluated or for whom the information was available.
b Persistence of viable cryptococci in cultured samples.
FIG1 ComparisonofDNAcontentsandvirulenceofhaploidanddiploidA
C.neoformansisolatesrecoveredduringhumanormurineinfections.(A)Cells
were stained with propidium iodide to measure DNA content in comparison
with that of reference haploid strain H99. Ploidy was determined for single-
colonyisolates(AD7-99andAD8-18)puriﬁedfromclinicalsampleAD1-77,
as well as a single colony (AD 10-30) recovered from the brain of a mouse
inoculated with AD 7-99. (B) Three groups of seven outbred male mice were
inoculatedintravenouslywith105cellsofhaploid(AD7-99)ordiploid(AD8-
18) strains puriﬁed from the clinical sample or the diploid strain (AD 10-30)
recovered from the mouse brain. Differences in survival were analyzed using
Stata (SE) version 10 (Stata Corporation, College Station, TX). The strains of
clinical origin showed no statistically signiﬁcant differences in virulence (P 
0.056). Mice infected with the diploid strain of murine origin (AD 10-30)
survived signiﬁcantly longer than did mice infected with the strains of clinical
origin (P  0.001, log-rank test).
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sispeciation in the host, have been found in a single patient (36,
37).Hereweshowedthatalmost20%ofcryptococcosiscaseswere
associated with multiple strains of the fungal pathogen C. neofor-
mans.
Only anecdotal reports of mixed infections have been pub-
lishedpreviously(6–11).Previousexperimentswithmiceshowed
that infection with multiple strains of C. neoformans inoculated
via the intranasal or intravenous route can result in mixed infec-
tions in the lungs and/or brain (15, 38, 39). The presence of mul-
tiple strains in the environment makes it likely that multiple
strains could be acquired by human hosts. Our data showed the
presence of multiple varieties of C. neoformans (both serotypes A
and D), genetically unrelated isolates of the same variety, and AD
hybrid strains in the same patient. Because C. neoformans can
generate latent infections that reactivate upon immunosuppres-
sion (1), these different isolates could have been acquired by the
patient either simultaneously or over time. Furthermore, less vir-
ulent strains (such as serotype D or diploid strains) could be
clearedpriortodiseasemanifestation,resultingintheisolationof
onlythemorevirulentstrains(serotypeAMAT)inthemajority
of patients (6, 20, 27). Furthermore, an experimental model of
cryptococcosishasshownthatthepresenceofanestablishedcryp-
tococcalinfectiondoesnotpreventinfectionwithasecondstrain,
althoughitcanalterthekineticsoftheinfection(38).Thescarcity
of mixed-infection reports could also be due to technical bias.
Indeed, the routine clinical practice of analyzing single-colony
isolates obtained from a single anatomical site would make the
discovery of mixed infections unlikely.
In cases where genetically related haploid and diploid strains
were found during the course of infection in the same patient, it
wasimportanttodeterminetheoriginofthediploidstrain.These
infections could have resulted from either coinfestation with dif-
ferent strains or in vivo diploidization. This diploidization could
occur through same-sex cell fusion or endoreplication. Coinfec-
tionwithbothhaploidanddiploidstrainscouldalsofollowploidy
changesintheenvironment(21).However,thediscoveryofstable
diploid isolates in murine tissues following inoculation of an A
haploid isolate demonstrated that changes in ploidy can occur in
vivo. Previous studies using laboratory-derived isolates had not
observed in vivo diploidization (29). Our observation of dip-
loidization in clinical isolates is likely due to the overall ﬁtness of
the newly isolated clinical strains and their limited subculture in
the laboratory. The sources of mixed infections are thus multiple
simultaneous or sequential infestations from the environment, as
well as ploidy changes during infection progression.
Inoculationofdifferentiallylabeledstrainsandtheobservation
of their proximity within host capillaries show that in vivo cell
fusion is physically possible. Same-sex fusion has been described
in vitro for both C. neoformans var. neoformans (both mating
types) and C. neoformans var. grubii (mating type ) (22, 23).
Coinfection with a wild-type A haploid isolate and an NAT-
FIG 2 Colocalization of different strains following intravenous inoculation. C. neoformans strains KN99a and KN99 were stained with Alexa Fluor 594 (red)
and350(blue),respectively.Micewereinoculatedviathetailveinwith5106KN99acellsandthen5106KN99cells.At24hpostinoculation,theanimals
were sacriﬁced and their brains were harvested for immunoﬂuorescence. Frozen sections were immunostained with anti-collagen IV primary antibody with an
FITC (green)-labeled secondary antibody to identify capillary endothelial cells. Bar, 20 m.
TABLE 3 Evaluation of CHS1 and NAT gene copy numbers for haploid and diploid isolates recovered from infected mouse tissues by quantitative
PCR
Strain(s) and DNA amt CHS1 Cpa NAT Cp CHS1/NAT Cp ratio
NAT-resistant haploid AD 1-25
100 ng 23.99 23.12 1.038
50 ng 25.29 24.99 1.012
20 ng 28.69 27.58 1.040
10 ng 29.70 28.54 1.041
5 ng 30.89 29.88 1.034
2 ng 32.79 31.56 1.039
1 ng 34.78 32.48 1.071
Wild-type haploid AD 7-99 26.27 35
NAT-resistant haploid isolates from infected tissues (n  6)b 27.35  1.48 26.43  1.38 1.03  0.02
NAT-resistant diploid isolates from infected tissues (n  30)b 26.43  2.00 25.59  1.78 1.03  0.02
a Cp, crossing point.
b Values are means  standard deviations.
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vivo resulted from cell fusion and/or endoreplication. Of the 30
diploid NAT-resistant isolates from infected tissue that we ana-
lyzed, all had two copies of the NAT gene, suggesting that the
observed diploidization was due to endoreplication. In a recent
report,ploidychangesleadingtotheproductionoftitancellswith
up to eight times the normal DNA content were observed in the
lungs of mice (40). It remains unclear whether the diploidization
observedinourclinicalisolatesisrelatedtotitancellformationor
occurs via another, unrelated, process.
Thedemonstrationthatshuttlingbetweendiploidandhaploid
statesoccurredinvivoreinforcedrecentﬁndingsobtainedinvitro
(21). A mixture of both populations may provide better adapta-
tion to the environment in nature and in the host. Lin and col-
leagues found that autodiploids represent the most common type
of diploid in C. neoformans populations in the environment and
suggested that their function may be to generate genetic diversity
denovoduringthesexualcycle(21).Theabilitytoproducediploid
cells may prove beneﬁcial to cryptococcal cells by allowing rapid
evolution of genes (20, 21) or by increasing drug resistance, as
showninCandidaalbicans(41)inresponsetoenvironmentaland
host challenges. While we did not detect differences in antifungal
susceptibilityproﬁlesbetweenourAhaploidanddiploidstrains
(data not shown), we cannot rule out the possibility that ploidy
changes in other strains could explain some treatment failures
(Table 2). Interestingly, while drug treatment failure rates may
increase in patients with mixed infections, death rates may also
decrease,althoughneithercharacteristicreachedstatisticalsignif-
icance. These paradoxical ﬁndings could be explained by interac-
tions between coinfecting strains that have been shown to de-
crease pathogenesis in experimental models (15). However, the
relatively small number of patients studied here prevents deﬁni-
tive conclusions about a relationship between a mixed infection
and the outcome of the infection. Further studies of humans and
in the experimental models are needed to explore this hypothesis.
The discovery that mixed infections are common is a major
ﬁnding for the management of cryptococcosis and other infec-
tions, especially those with environmentally acquired fungi, such
asHistoplasmacapsulatum,Blastomycesdermatitidis,andAspergil-
lus spp. Future drug design—including vaccine—strategies need
to take into account the complex nature of cryptococcal infec-
tions. The use of unpuriﬁed clinical isolates was vital to these
experiments. Thus, while Koch’s postulates can be used to deﬁne
thataspeciﬁcorganismiscausingaspeciﬁcclassofdisease—such
asC.neoformanscausingcryptococcosis—careshouldbetakenin
extrapolatingthesepostulatestotheclinicalsetting.Ourdatasug-
gest, in the context of fungal infections, that clonal infections can
cause disease but clinical disease is not always caused by clonal
infections.Thisconceptmayapplybroadlytoothermicrobesand
shouldbeconsideredinthecurrenterawhenamultiplicityofnew
tools and approaches can be used to determine the clonality of
infections.
MATERIALS AND METHODS
Ethicsstatement.TheCryptoA/Dstudywasapprovedbythelocalethical
committeeandreportedtotheFrenchMinistryofHealth(registrationno.
DGS970089). Patients enrolled in the CryptoA/D study gave written in-
formed consent for a systematic workup. Data were analyzed anony-
mously.AllanimalexperimentsweredoneinaccordancewiththeInstitut
Pasteur’s institutional guidelines (approved protocol CHST no. 03-144).
C. neoformans strains. Clinical cultures were collected during the
prospective multicenter CryptoA/D study implemented at the National
Reference Center for Mycoses and Antifungals (NRCMA) between 1997
and2001(30).Thestudywasapprovedbythelocalethicalcommitteeand
reported to the French Ministry of Health (registration no. DGS970089).
Patients enrolled in the CryptoA/D study gave written informed consent
for a systematic workup. This included cultures from CSF, blood, and
urine samples, as well as cultures from skin lesions or BAL ﬂuid when
appropriate.Originalculturescorrespondtotheculturesobtainedineach
clinical mycology laboratory after culture of the biological specimens on
agar plates or in tubes. These original cultures were directly sent to the
NRCMA prior to any puriﬁcation step or freezing. The original cultures
were not puriﬁed prior to storage at 80°C and serotyping at the
NRCMA. The selection of the 100 original cultures used for the present
studywas“random”(onaﬁrstfound/ﬁrststudiedbasis)andnotbasedon
the patients’ characteristics or serotyping results. When available, all of
the original cultures from the same patient (recovered from different an-
atomicalsitesandatdifferenttimesduringtheepisodeofcryptococcosis)
were analyzed. A suspension of approximately 103 cells/ml from the orig-
inal culture was plated on Sabouraud agar plates. Single CFU resulting
from the multiplication of a single cell were subcultured for further anal-
ysis.
ThefollowingC.neoformanslaboratoryreferencestrainswereusedfor
comparison: JEC21 (serotype D MAT [42]), B3502 (serotype D MATa
[43]), H99 (serotype A MAT [44]), KN99a (serotype A MATa), and
KN99 (serotype A MAT [19]).
Determination of ploidy using ﬂow cytometry. Cells were prepared
for ﬂow cytometry by using the protocol described previously (45). Data
were acquired from 30,000 cells using the FL2 channel of a BD FACScan
ﬂow cytometer (Becton Dickinson & Company, Franklin Lakes, NJ). The
ﬂuorescence-activated cell sorter proﬁle of original cultures or single-
colony isolates was compared with that obtained with haploid reference
strainH99todetermineploidy.AnalysiswasperformedusingCellQuest
software version 3.3 (BD Biosciences, San Jose, CA).
Determination of mating type and serotype using MAT/serotype-
speciﬁcprimers.Originalculturesandsingle-colonyisolatesweregrown
for24hat28°Consolidyeastnitrogenbasemedium.DNAwasextracted
using the High Pure PCR template preparation kit (Roche Applied Sci-
ence, Indianapolis, IN) according to the manufacturer’s instructions.
PCRs were performed on an iCycler thermocycler (Bio-Rad, Hercules,
CA) using primers speciﬁc for the serotype A or D SXI1/SXI2a and
STE20/a loci to determine the mating type and serotype (25). Results
were conﬁrmed using serotype-speciﬁc primers for the PAK1 and GPA1
genesonalloriginalculturesandselectedsingle-colonyisolates(25).Lab-
oratory reference strains were used as positive controls.
MLST. MLST was performed on all A isolates from patients with
mixed infections. Eight MLST loci (CAP59, URA5, GPD1, SOD1, LAC1,
IGS1,PLB1,andTEF1),includingsixlocidescribedforC.neoformansvar.
grubii by Litvintseva et al. (46) and two chosen by the Isham cryptococcal
genotyping working group (47), were examined. Both strands of puriﬁed
ampliﬁed fragments were sequenced at the sequencing facility (PF-8) of
theInstitutPasteuronanABIPrism3700DNAanalyzer(AppliedBiosys-
tems, Courtaboeuf, France), with the same primers that were used in the
PCR steps. Sequences edited with Chromas Pro version 1.41 (Technely-
sium Pty. Ltd., Helensvale, Queensland, Australia) were compared with
theallelesequencesoftheC.neoformansvar.grubiiMLSTdatabase(http:
//cneoformans.mlst.net/), and new allelic sequences were submitted.
For serotype D, MLST proﬁles were determined for the same eight
loci.ThesameprimerswereusedforthePCRampliﬁcationandsequenc-
ingofsevenloci(CAP59,URA5,GPD1,LAC1,IGS1,PLB1,andTEF1),but
for SOD1, new primers were designed based on the JEC21 sequences
(GenBank accession no. AE017344) (Table 4). For the eight loci, the PCR
conditionsandthestartandendpointsofthesequenceswerethesameas
those for serotype A. The serotype D MLST database is being currently
developedattheImperialCollegeLondon,andMLSTallelicsequencesfor
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genotyping working group and will be available online when the serotype
D MLST database is established.
For AD hybrid isolates, portions of the CAP10 and URE1 loci were
ampliﬁed according to Lin et al. (27). The MLST locus SOD1, ampliﬁed
with serotype A-speciﬁc primers, was also analyzed. In order to improve
the typing method for the AD hybrid isolates, new primers speciﬁc for
serotype A were designed for the PLB1 and TEF1 loci (Table 4). For the
design of these new primers, nucleotide sequences of serotype D strain
B3501 (GenBank accession no. AF238241 for locus PLB1 and positions
355113 to 355970 of the contig chr13.b3501.040506 from the Stanford
database [http://www-sequence.stanford.edu/group/C.neoformans
/index.html] for locus TEF1) and serotype A strain H99 (GenBank acces-
sion no. AF223383 for locus PLB1) or M1-106 (GenBank accession no.
U81804 for locus TEF1) were compared. The PCR conditions were mod-
iﬁedasfollows:35cyclesofannealingat52°CforPLB1and58°CforTEF1
andthenelongationat72°Cfor1min.FortheSOD1,PLB1,andTEF1loci,
sequences were also compared with the allele sequences of the MLST
database.
NAT-resistant isolate construction. An NAT-resistant isolate of
AD7-99wasgeneratedbygeneinsertionaspreviouslydescribed(15,48).
The NAT transgene (NAT) was inserted into a noncoding region down-
stream of the LYS2 gene coding region located on chromosome 5. PCR
was used to generate the 5= (KN0140 and KN0129) and 3= (KN0139 and
KN0122)ﬂankingregionscontaininglinkerstoaNATrcassette,andover-
lap PCR was used to generate the full-length NAT insertion construct
(Table4).Theinsertionconstructwasintroducedbybiolistictransforma-
tion into AD 7-99 to generate NAT-resistant strain AD 1-25. Proper in-
sertion was veriﬁed by PCR using primers external to the integration site
(KN0177 and KN0176) and Southern hybridization (not shown).
Experimentalinfections.Yeastsuspensionsforinoculationwerepre-
pared from single-colony isolates after subculture for 18 h in liquid yeast
extract-peptone-dextrose (YPD) with or without NAT (100 ng/ml;
Werner Bioagents, Germany) and washed three times in phosphate-
buffered saline (PBS; Sigma). Six-week-old outbred OF1 male mice
(Charles River, L’Arbresle, France) were inoculated intravenously. Mice
were euthanized by CO2 inhalation at various times after inoculation or
when unable to reach food because of disease progression. Organs were
aseptically removed, homogenized in 1 ml sterile PBS, and plated on Sa-
bouraudagarcontaining0.5mg/mlchloramphenicoland/oronYPDagar
containing NAT at 100 ng/ml.
To analyze whether two cells of C. neoformans could come into close
contact within the host, congenic strains KN99a and KN99 (19) were
stained as described in reference 40, with Alexa Fluor 594 (red) or 350
(blue), respectively. Mice were inoculated via the tail vein with 5  106
KN99a (red) cells and then 5  106 KN99 (blue) cells. At 24 h postin-
oculation, animals were sacriﬁced and perfused with 20 ml PBS and then
20 ml 4% paraformaldehyde (PFA). Brains were harvested, placed in 4%
PFA, followed by a 40% (wt/vol) sucrose solution in PBS, frozen in iso-
pentane and liquid nitrogen, stored at 80°C, and cut into 50-m sec-
tions. Slides were washed in PBS for 15 min and then incubated with
100 l trypsin-EDTA (Invitrogen) at 37°C for 10 min. Slides were then
washed in PBS containing 20% fetal calf serum (Invitrogen) for 10 min,
blocked with PBS containing 20% fetal calf serum, 0.1% bovine serum
albumin (BSA), and 0.1% Triton X-100 (Sigma, St. Louis, MO) for
20 min, and then washed with PBS containing 0.1% Triton X-100. Anti-
collagenIVantibody(Chemicon)wasdiluted1:50inPBSwith0.1%BSA
and0.1%TritonX-100.Antibody-treatedslideswereincubatedovernight
at4°CandthenwashedinPBS.Fluoresceinisothiocyanate(FITC;green)-
labeled goat anti-rabbit antibody (Invitrogen) was diluted 1:200 and
addedtotheslides.After3hofincubationat37°C,theslideswerewashed
three times in PBS for 15 min and mounted in Vectashield mounting
medium. Slides were imaged by ﬂuorescence microscopy, and z stack
images were captured with an Apotome-equipped Zeiss Axioplan micro-
scope.Extendedfocuswasusedtovisualizetherelationshipbetweencells
within the z stack using Zeiss AxioVision software.
To study ploidy changes in vivo, eight mice were inoculated in two
independent experiments with 103 cells of AD 7-99, a haploid serotype A
MATsingle-colonyisolatefromtheoriginalstrainAD1-77culture(pa-
tientno.161).Miceweresacriﬁcedat3,7,9,and15dayspostinoculation.
Spleens,lungs,andbrainswereplatedonSabouraudagar.Thenumberof
CFU was determined, and single-colony isolates (10 to 12 for spleens or
lungs, 24 to 56 for brains) were analyzed for DNA content.
Forsurvivalstudies,mice(seven/group)wereinoculatedwith105cells
of strain AD 7-99 (haploid), a diploid single-colony isolate from patient
no. 161 (AD 8-18), or a diploid single-colony isolate from a mouse brain
(AD 10-30). Mice were monitored twice daily, and those in pain or sick
were sacriﬁced by CO2 inhalation.
Coinfection with AD 1-25 and AD 7-99 was used to assess whether
diploidisolatesresultedfromendoreplicationorcellfusion.AD1-25was
compared to AD 7-99 for stability and virulence in vivo. CFU counts on
Sabouraud agar containing 0.5 mg/ml chloramphenicol and YPD agar
containing 100 g/ml NAT at 7 and 15 days postinoculation were com-
pared and found to be equivalent. Mice (n  6) were then coinoculated
with 104 cells each of AD 7-99 (wild type) and AD 1-25 (NAT resistant).
Mice were sacriﬁced at 7 and 15 days postinoculation. Lungs and brains
were removed, homogenized, and plated on YPD agar containing
100 g/ml NAT in order to select isolates resistant to NAT. CFU were
enumerated, and single-colony isolates (at least 20 per organ) were ana-
lyzed as described above for ploidy determination.
TABLE 4 Sequences of primers designed for MLST locus SOD1 speciﬁc for serotype D, for MLST loci PLB1 and TEF1 speciﬁc for serotype A, for
NAT insertion, and for quantitative PCR
Locus Primer Sequence (5=–3=) Amplicon size (bp)
SOD1 SOD1Df TCTAGTCAAAATGGTCAAGG 643
SOD1Dr CGCAGCCGTTCGTTTGGACG
PLB1 PLB1serAf GCCACGGGTACTTTTGC 821
PLB1serAr CGCTCGGGTAAAACATGAG
TEF1 TEF1f AATCGTCAAGGAGACCAACG 993
TEF1serAr GCTCTTCCCATCGGACTTC
5= ﬂanking region for NAT insertion KN0140 TGCTCACATCCTCGCAGCACACCACAGATCCAAAACCC
KN0129 GCAACCTTGGTTTGAAGAGC
3= ﬂanking region for NAT insertion KN0139 CCGTGTTAATACAGATAAACCCGAAGGGACCAGTCACAAGT
KN0122 AACCTGACGGAAGAGCAGAA
Outside 5= integration check KN0177 CGTCATCAAACCTAGCAGCATTCG
Outside 3= integration check KN0176 CTCGAGACCAAGATCAAGATTGCC
CHS1 CHS1f GTCCCAGGAGGACTCCTTTC 168
CHS1r TGTCGTTCAGGTCGAGTGAG
NAT KN0192 GGTGACGCGGAAGACGGTGT 123
MD001 GTATGGCGGCCGCCACTCT
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transientstage,twogroupsofsevenmicewereinoculatedwiththediploid
strain recovered from the clinical culture (AD 8-18) and from the mouse
brain (AD 10-30). Mice were sacriﬁced at 3, 7, and 15 days postinocula-
tion. Lungs and brains were removed, homogenized, and plated on
Sabouraud-chloramphenicol agar. CFU were enumerated, and single-
colonyisolates(atleast16perorgan)wereanalyzedasdescribedabovefor
ploidy determination.
Quantitative PCR. To determine if diploid isolates resulted from en-
doreplication or cell fusion between AD 7-99 (wild-type isolate) and
AD 1-25 (NAT resistant), quantitative PCR was performed. DNA was
extractedasdescribedabovefrom30diploidand6haploidNAT-resistant
isolatesrecoveredfromcoinfectedmice.Primersweredesignedtoamplify
part of the CHS1 gene, located on chromosome 8, as an internal control
(Table 4). Because CHS1 is present in both the AD 7-99 and AD 1-25
strains, two copies of the gene should be present in the diploid cells,
irrespective of whether they were formed by endoreplication or cell fu-
sion. Primers were designed to amplify part of the NAT gene (chromo-
some 5) (Table 4). The NAT gene is present only in AD 1-25, so diploid
cells generated by endoreplication would have two copies, whereas those
generatedbycellfusionbetweenAD7-99andAD1-25wouldhaveonlya
single copy. Quantitative PCR was performed with a LightCycler LC480
(Roche Applied Science, Germany) in a ﬁnal volume of 20 l containing
0.75 l of each primer at 10 M, 10 l of Sybr green master mix 2,
9.25 l of water, and 2 l of DNA. The conditions were similar for the
ampliﬁcation of both the CHS1 and NAT insertions: 5 min at 95°C, 40
cycles of 15 s at 95°C and 60 s at 60°C, and then 1 min at 95°C and 1 min
at 60°C with a melting curve temperature range of 55°C to 95°C. Haploid
parental strain AD 1-25 was used for a standard curve using known DNA
amounts of 100 ng, 50 ng, 20 ng, 10 ng, 5 ng, 2 ng, and 1 ng determined
with a NanoDrop 8000 spectrophotometer (Thermo Fisher Scientiﬁc).
Foreachisolate,theratioofthecrossingpointsobtainedforampliﬁcation
of the CHS1 gene and the NAT gene was calculated to determine if the
diploid isolates had the same (endoreplication) or half (cell fusion) the
amount of NAT DNA compared to CHS1 DNA.
Statistical analysis. Comparisons between groups were done using
chi-square or Fisher’s exact tests for categorical variables and Student’s
t test or one-way analysis of variance for continuous variables. Survival
curveswerecomparedbythelog-ranktest.DatawereanalyzedusingStata
Statistical Software (Stata 10.0; Stata Corporation, College Station, TX).
P values of less than 0.05 were considered signiﬁcant.
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